rs1800716
From SNPedia
| Merged into | rs3892097 |
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 |
| Make rs1800716(A;A) |
| Make rs1800716(A;G) |
| Reference | GRCh38 38.1/142 |
| Chromosome | 22 |
| Position | 42524947 |
| Gene | CYP2D6 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1800716 |
| dbSNP (classic) | rs1800716 |
| ClinGen | rs1800716 |
| ebi | rs1800716 |
| HLI | rs1800716 |
| Exac | rs1800716 |
| Gnomad | rs1800716 |
| Varsome | rs1800716 |
| LitVar | rs1800716 |
| Map | rs1800716 |
| PheGenI | rs1800716 |
| Biobank | rs1800716 |
| 1000 genomes | rs1800716 |
| hgdp | rs1800716 |
| ensembl | rs1800716 |
| geneview | rs1800716 |
| scholar | rs1800716 |
| rs1800716 | |
| pharmgkb | rs1800716 |
| gwascentral | rs1800716 |
| openSNP | rs1800716 |
| 23andMe | rs1800716 |
| SNPshot | rs1800716 |
| SNPdbe | rs1800716 |
| MSV3d | rs1800716 |
| GWAS Ctlg | rs1800716 |
| Status | Merged into rs3892097 |
| Max Magnitude | 0 |
a variation in CYP2D6
[PMID 18547414
] Genotyping panel for assessing response to cancer chemotherapy.
[PMID 24265353] The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen
